✦ LIBER ✦

The role of alendronate in mitigating perimenopausal bone loss: a double-blind randomized controlled pilot study

✍ Scribed by Jennifer E. Mersereau; Claire Khouri; Robert B. Jaffe

Book ID: 116476539
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 69 KB
Volume: 94
Category: Article
ISSN: 1556-5653
DOI: 10.1016/j.fertnstert.2009.11.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Alendronate (ALN) on Bone Mineral Density (BMD) and Bone Turnover in Perimenopausal Women With Low BMD

✍ Khan, A.; Dubois, S.; Rahman, Z.; Khan, O.A.; Derzko, C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Tolerability of Once-Weekly Alendronate

Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study

✍ Greenspan, Susan; Field-Munves, Ellen; Tonino, Richard; Smith, Mary; Petruschke, 📂 Article 📅 2002 🏛 Mayo Clinic 🌐 English ⚖ 96 KB

The role of adipokines in rosiglitazone-

The role of adipokines in rosiglitazone-induced bone loss: A randomized, prospective, double-blinded trial

✍ T. Harsløf⁎; S.B. Pedersen; B.L. Langdahl 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Zonisamide in the Treatment of Painful D

Zonisamide in the Treatment of Painful Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

✍ Aysel Atli; Sunil Dogra 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Rifaximin for the treatment of active po

Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study

✍ Kim L. Isaacs; Robert S. Sandler; Maria Abreu; Michael F. Picco; Stephen B. Hana 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## Background: The efficacy of the nonabsorbable antibiotic rifaximin in patients with active acute or chronic pouchitis is unknown. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of rifaximin in patients with active pouchitis. eighteen patients with

A 1-Year Randomized, Double-Blind, Place

A 1-Year Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Ibandronate on Bone Loss Following Renal Transplantation

✍ K. T. Smerud; S. Dolgos; I. C. Olsen; A. Åsberg; S. Sagedal; A. V. Reisæter; K. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 667 KB